Petros pharmaceuticals reports first quarter 2022 financial results and provides corporate update

New york, may 16, 2022 (globe newswire) -- petros pharmaceuticals, inc. (“petros” or “the company”) (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announced financial results for the first quarter ended march 31, 2022.
PTPI Ratings Summary
PTPI Quant Ranking